CFAO Healthcare has acquired the South African operations of Sanofi's Consumer Health division, Opella Healthcare South Africa, marking its first entry into the South African pharmaceutical market.

Target Information

CFAO Healthcare has successfully entered the South African pharmaceutical market through its acquisition of the South African operations of Sanofi's Consumer Health division, known as Opella Healthcare South Africa. This acquisition marks CFAO's first investment in the healthcare sector in South Africa, a key market that is recognized as the second largest in the continent. Following the acquisition, the new entity will operate under the name CFAO Healthcare in South Africa.

CFAO Healthcare, a division of the CFAO Group, is dedicated to ensuring access to quality medications across Africa. They engage in the manufacture, distribution, and provision of pharmaceutical and medical products, alongside related services. With a presence in 28 countries, this acquisition strengthens CFAO Healthcare’s role as a leading pan-African distributor of pharmaceutical products, emphasizing its commitment to integrating efficiently across the entire value chain.

Industry Overview

South Africa boasts one of the most developed healthcare systems in Africa, characterized by a mix of public and private sectors. The pharmaceutical industry is a vital component of this system, playing a critical role i